Page 76 - Read Online

Martin et al. Microbiome Res Rep 2023;2:17 https://dx.doi.org/10.20517/mrr.2023.10 Page 13 of 13

115. Smith DR, Temime L, Opatowski L. Microbiome-pathogen interactions drive epidemiological dynamics of antibiotic resistance: a
modeling study applied to nosocomial pathogen control. Elife 2021:10. DOI PubMed PMC
116. Martinez FA, Balciunas EM, Converti A, Cotter PD, de Souza Oliveira RP. Bacteriocin production by Bifidobacterium spp. A
review. Biotechnol Adv 2013;31:482-8. DOI PubMed
117. Liu G, Ren G, Zhao L, Cheng L, Wang C, Sun B. Antibacterial activity and mechanism of bifidocin A against Listeria
monocytogenes. Food Control 2017;73:854-61. DOI
118. Mahdi LH, Laftah AR, Yaseen KH, Auda IG, Essa RH. Establishing novel roles of bifidocin LHA, antibacterial, antibiofilm and
immunomodulator against Pseudomonas aeruginosa corneal infection model. Int J Biol Macromol 2021;186:433-44. DOI PubMed
119. Fukuda S, Toh H, Hase K, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature
2011;469:543-7. DOI
120. Walker AW, Duncan SH, McWilliam Leitch EC, Child MW, Flint HJ. pH and peptide supply can radically alter bacterial populations
and short-chain fatty acid ratios within microbial communities from the human colon. Appl Environ Microbiol 2005;71:3692-700.
DOI PubMed PMC
121. Park SY, Rao C, Coyte KZ, et al. Strain-level fitness in the gut microbiome is an emergent property of glycans and a single
metabolite. Cell 2022;185:513-529.e21. DOI PubMed PMC
122. Shelton CD, Yoo W, Shealy NG, et al. Salmonella enterica serovar Typhimurium uses anaerobic respiration to overcome propionate-
mediated colonization resistance. Cell Rep 2022;38:110180. DOI PubMed PMC
123. Jacobson A, Lam L, Rajendram M, et al. A gut commensal-produced metabolite mediates colonization resistance to salmonella
infection. Cell Host Microbe 2018;24:296-307.e7. DOI PubMed PMC
124. Becattini S, Littmann ER, Carter RA, et al. Commensal microbes provide first line defense against Listeria monocytogenes infection.
J Exp Med 2017;214:1973-89. DOI PubMed PMC
125. Caballero S, Kim S, Carter RA, et al. Cooperating commensals restore colonization resistance to vancomycin-resistant enterococcus
faecium. Cell Host Microbe 2017;21:592-602.e4. DOI PubMed PMC
126. Kim SG, Becattini S, Moody TU, et al. Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus.
Nature 2019;572:665-9. DOI
127. Aires J. First 1000 days of life: consequences of antibiotics on gut microbiota. Front Microbiol 2021;12:681427. DOI PubMed
PMC
128. Ramirez J, Guarner F, Bustos Fernandez L, et al. Antibiotics as major disruptors of gut microbiota. Front Cell Infect Microbiol
2020;10:572912. DOI PubMed PMC
129. Bokulich NA, Chung J, Battaglia T, et al. Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci Transl
Med 2016;8:343ra82. DOI PubMed PMC
130. Martín R, Langella P. Emerging health concepts in the probiotics field: streamlining the definitions. Front Microbiol 2019;10:1047.
DOI PubMed PMC
131. Hill C, Guarner F, Reid G, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics
consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014;11:506-14. DOI
132. Sanders ME, Merenstein D, Merrifield CA, Hutkins R. Probiotics for human use. Nutr Bull 2018;43:212-25. DOI
133. Han S, Lu Y, Xie J, et al. Probiotic gastrointestinal transit and colonization after oral administration: a long journey. Front Cell Infect
Microbiol 2021;11:609722. DOI PubMed PMC
134. Zmora N, Zilberman-Schapira G, Suez J, et al. Personalized gut mucosal colonization resistance to empiric probiotics is associated
with unique host and microbiome features. Cell 2018;174:1388-1405.e21. DOI